Statement by Malaria No More CEO Martin Edlund:
“We are inspired by the innovation and persistence of scientists and researchers around the world who are committed to ending malaria. This step in WHO’s careful evaluation of the world’s first malaria vaccine is an example of the system working as it should. This vaccine is not a silver bullet, but it is an important first step in the kind of product development we need. Fortunately, the pipeline for malaria products has never been stronger. We need continued public and private investment to accelerate eradication. Innovation in potentially game-changing technologies such as more sensitive diagnostics, new treatment formulations and innovative vector control is well underway and could be available within the next decade. There is growing momentum to end this disease within our generation. If we redouble our investments and our resolve, we can succeed.”
Malaria No More CEO Martin Edlund is available for press interviews. Please contact Global Communications Manager Dena Gudaitis to arrange.
Martin Edlund will chair a panel focused on the research and technologies required to make malaria eradication a reality at the American Society of Tropical Medicine and Hygiene (ASTMH) conference in Philadelphia. The panel discussion will take place at 8-9:30 a.m. on October 28th in the Philadelphia Marriott Downtown, Liberty Ballroom Salon C.